Category: 3-DailySometimeCommentary

Last week, Time Magazine released photos of a 29-year-old Justin Trudeau in blackface. In the days following, the Canadian Prime Minister admitted to two more instances of using blackface. The Canadian election is a month away. How will Trudeau’s latest scandal effect it?

Guest: Jesse Brown, host of Canadaland podcast.

Podcast production by Mary Wilson, Jayson De Leon, Danielle Hewitt and Mara Silvers

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Somewhere in Washington right now there is a whistleblower. We don’t know who they are, what their job is, or if they’re a man or a woman. The only thing we do know is that they are in the middle of a political firestorm. So, how did this all come about? And will it be enough to push Congress to act?

Guest: Shane Harris, covers intelligence and national security for the Washington Post.

To learn more about the Hunter Biden story, check out our episode from earlier this summer: "The Cloud Over Joe Biden's Son."

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Prime Minister Narendra Modi held his first rally in the U.S. when he was elected in 2014. Now, he’s coming back to appear in front of 50,000 people in Houston, Texas. The other person expected to take the stage is President Trump. So, what do the leaders of the world’s two largest democracies plan to gain from the visit?

Guest: Milan Vaishnav, director of the South Asia Program at the Carnegie Endowment for International Peace.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A buzzy new drug to help treat people with a peanut allergy was recommended for approval by an FDA advisory board this week. It would be the first government-approved method intended to combat these kinds of allergic reactions. The story behind that drug helps explain how the cost of many prescription drugs ends up being so high.

Guest: James Hamblin, staff writer at The Atlantic.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices